Norhydromorphone | 14696-23-2

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 吗啡烷
• 英文名称: Norhydromorphone
• 英文别名: (-)-4,5-epoxy-3-hydroxymorphinan-6-one；N-norhydromorphone；4,5α-epoxy-3-hydroxy-morphinan-6-one；4,5α-Epoxy-3-hydroxy-morphinan-6-on；(4R,4aR,7aR,12bS)-9-hydroxy-2,3,4,4a,5,6,7a,13-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
• CAS: 14696-23-2
• 化学式: C₁₆H₁₇NO₃
• 分子量: 271.316
• InChiKey: SWIRXSKBBSJXGY-UIHHKEIPSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  20
• 可旋转键数：
  0
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  58.6
• 氢给体数：
  2
• 氢受体数：
  4

ADMET

代谢

去氢吗啡是已知的人类代谢产物。

Norhydromorphone is a known human metabolite of Hydromorphone.

来源:NORMAN Suspect List Exchange

反应信息

• 作为反应物：
  描述：

  Norhydromorphone 在 盐酸 、 potassium carbonate 、 氯化铵 、 copper(II) oxide 、 锌 作用下， 以 甲醇 、 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 13.0h， 生成 (-)-3,4-methylenedioxymorphinan-6-one
  参考文献：
  名称：

  氧化吗啡的结构-活性关系。七。4-羟基和3,4-二加氧的6-吗啡酮系列的5-甲基化和14-羟基取代的激动剂和拮抗剂

  摘要：

  通过常规化学方法制备了几种在C（3），C（4），C（5）和C（14）处不同取代的吗啡酮激动剂以及4-羟基和3,4-二甲氧基系列的拮抗剂。事实证明，海湾区域的氧化模式非常重要，包括C（3）和C（4）。C（5）处的烷基化或C（14）处的羟基化降低了化合物的效力。发现最有效的激动剂是N-苯乙基取代的酮27，其在热板测定中的效力是吗啡的六倍。3，4-亚甲基二氧基取代的酮9的效力比其3，4-二甲氧基同类物低约20倍。X射线分析9 且有代表性的激动剂表明，海湾地区的立体化学特征相似，因此不能用来解释这种差异。

  DOI：

  10.1002/hlca.19820650804
• 作为产物：
  描述：

  3,6-alpha-二甲氧基-4,5-alpha-环氧-17-甲基-吗喃 在 盐酸 、 ammonium hydroxide 、 二苯甲酮 、 potassium tert-butylate 、 氢溴酸 、 potassium carbonate 、 sodium hydroxide 作用下， 以 水 、 甲苯 为溶剂， 生成 Norhydromorphone
  参考文献：
  名称：

  去甲氢吗啡酮 N-苯乙基部分中取代基的有趣作用：来自一组“尾巴摇狗”实验的双功能阿片类药物

  摘要：

  (−)-N-苯乙基类似物的光学纯 N-去甲氢吗啡酮被合成并在几个体外试验中进行药理学评估（阿片受体结合、[35S]GTPγS 结合的刺激、毛喉素诱导的 cAMP 积累试验和 MOR 介导的 β-抑制素募集测定）。“体”和“尾”与阿片受体的相互作用（Portoghese 信息地址理论的一个子集）被用于分子建模和模拟，其中“地址”可以被认为是氢吗啡酮分子的“主体”和“信息”由 N-苯乙基部分芳环上的取代基（尾）传递。一种化合物，Np-chloro-phenethynorhydromorphone ((7aR,12bS)-3-(4-chlorophenethyl)-9-hydroxy-2,3,4,4a,5,6-hexahydro-1H-4,12-methanobenzofuro[3 ,2-e]isoquinolin-7(7aH)-one, 2i), 发现在 MOR 和 DOR 处具有纳摩尔结合亲和力。它是

  DOI：

  10.3390/molecules25112640

文献信息

• [EN] N-OXIDES OF 4,5-EPOXY-MORPHINANIUM ANALOGS<br/>[FR] N-OXYDES D'ANALOGUES 4,5-ÉPOXY-MORPHINANIUM
  申请人：PROGENICS PHARM INC

  公开号：WO2009067275A1

  公开（公告）日：2009-05-28

  Novel N-oxides of 4,5-epoxy-morphinanIum analogs are disclosed. Pharmaceutical compositions containing the N-oxides of 4,5-epoxy-morphinanium analogs and methods of their pharmaceutical uses are also disclosed. The compounds disclosed are useful, inter alia, as modulators of opioid receptors.

  揭示了4,5-环氧吗啡啉盐类的新型N-氧化物。还揭示了含有4,5-环氧吗啡啉盐类的N-氧化物的药物组合物，以及它们的药用方法。所揭示的化合物可用作阿片受体调节剂等用途。
• N-Oxides of 4,5-Epoxy-Morphinanium Analogs
  申请人：Perez Julio

  公开号：US20080234306A1

  公开（公告）日：2008-09-25

  Novel N-oxides of 4,5-epoxy-morphinanium analogs are disclosed. Pharmaceutical compositions containing the N-oxides of 4,5-epoxy-morphinanium analogs and methods of their pharmaceutical uses are also disclosed. The compounds disclosed are useful, inter alia, as modulators of opioid receptors.

  本发明公开了4,5-环氧-吗啡铵类似物的新型N-氧化物。本发明还公开了含有4,5-环氧-吗啡铵类似物的N-氧化物的制药组合物及其制药用途的方法。公开的化合物可用作阿片受体调节剂等用途。
• Identification and synthesis of norhydromorphone, and determination of antinociceptive activities in the rat formalin test
  作者：Ming Zheng、Keith M. McErlane、May C. Ong

  DOI：10.1016/j.lfs.2004.06.008

  日期：2004.11

  The main objective of this paper is to report the identification and synthesis of norhydromorphone, a novel metabolite of hydromorphone, and its antinociceptive activities when tested in the formalin test as compared to other known analgesics. In addition, we are reporting for the first time the lack of antinociceptive activities of hydromorphone-3-glucuronide, dihydromorphine-3-glucuronide and dihydroisomorphine-3-glucuronide in the rat formalin test. Norhydromorphone was isolated and identified as a metabolite of hydromorphone in a cancer patient's urine. An authentic standard of norhydromorphone was synthesized. The identity of norhydromorphone in the urine sample was confirmed by comparing the LC retention time and MS ion fragmentation with the synthetic standard using a liquid chromatographic-mass spectrometric-mass spectrometric (LC-MS-MS) assay. Norhydromorphone was found to be a minor metabolite of hydromorphone in the urine. Additionally, the antinociceptive activities of norhydromorphone, hydromorphone, morphine, dihydromorphine, dihydroisomorphine, hydromorphone-3-glucuronide, dihydromorphine-3-glucuronide and dihydroisomorphine-3-glucuronide were determined in the rat formalin test following intraperitoneal (i.p.) administration. Only limited antinociception was observed and no significant increase in antinociception was detected at the three doses tested. The increased polarity of norhydromorphone as compared to hydromorphone due to the primary piperidine nitrogen may make it less favorable to cross the blood-brain-barrier (BBB), which may be partly responsible. In addition, lower intrinsic antinociceptive activity, which remains to be determined, could also contribute to the low antinociception. Our results also show that hydromorphone was five times as potent as morphine in the formalin test, while dihydromorphine and dihydroisomorphine were equipotent to and 36% as potent as morphine, respectively. Hydromorphone-3-glucuronide, dihydromorphine-3-glucuronide and dihydroisomorphine-3-glucuronide did not exhibit any antinociceptive effect at the doses tested. The results further underscore the importance of a free C-3-OH to the analgesic effect of morphine alkaloids. (C) 2004 Elsevier Inc. All rights reserved.
• Bognar; Gaal, Izvestiya na Khimicheskiya Institut, Bulgarska Akademiya na Naukite, 1956, vol. 4, p. 473,476
  作者：Bognar、Gaal

  DOI：——

  日期：——
• LANGSTROEM, B.;ANTONI, G.;HALLDIN, C.;MALMBORG, P.;NAGREN, K.;RIMLAND, A.+, J. LABELLED COMPOUNDS AND RADIOPHARM., 1984, 21, N 11-12, 1200-1202
  作者：LANGSTROEM, B.、ANTONI, G.、HALLDIN, C.、MALMBORG, P.、NAGREN, K.、RIMLAND, A.+

  DOI：——

  日期：——